Search
Palatin Technologies Inc
PTNAdd to Watchlist
11.720USD
-0.520-4.25%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
11.41MMarket Cap
107.30P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Palatin Technologies Inc is 8.00, ranking 165 out of 389 in the Biotechnology & Medical Research industry. The average price target is 51.50, with a high of 53.00 and a low of 50.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
53.500
Target Price
+336.73%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Palatin Technologies Inc
PTN
3
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Palatin Technologies Inc's expected revenue for the next quarter?
Palatin Technologies Inc's expected revenue is 1.25M.
What is Palatin Technologies Inc's price target?
Analysts forecast that Palatin Technologies Inc's price target is USD 51.50, with the highest forecast at USD 53.00 and the lowest forecast at USD 50.00.
How have Palatin Technologies IncPTN's recent earnings per share performed?
The market expectation was USD -0.37, while Palatin Technologies IncPTN's earnings per share (EPS) for the previous quarter was USD -2.86. EPS for the next quarter is expected at USD -1.20.
What is the analyst rating for Palatin Technologies Inc?
Based on the ratings of Palatin Technologies Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
